These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30801878)

  • 1. Utility of laboratory monitoring during hepatitis C treatment with ribavirin-free direct-acting antiviral regimens.
    VanOpdorp JR; Ferrentino N; Strader DB; Lidofsky SD
    J Viral Hepat; 2019 Jun; 26(6):778-781. PubMed ID: 30801878
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin.
    Todorovska B; Joksimovic N; Caloska-Ivanova V; Dimitrova-Genadieva M; Trajkovska M; Curakova E; Kiprijanovska S; Zafirova-Ivanovska B; Serafimoski V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar; 38(1):25-33. PubMed ID: 28593897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.
    Tabernilla A; Grandal M; Pernas B; Castro-Iglesias A; Rodríguez-Osorio I; Mena A; Delgado M; Cid P; Pedreira JD; Poveda E
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):781-785. PubMed ID: 28410351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of virological response on sustained virological response in hepatitis C patients].
    Zhou YQ; Wang XH; Fan Y; Zhu Y; Tan WT; Mao Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):944-6. PubMed ID: 20038340
    [No Abstract]   [Full Text] [Related]  

  • 6. Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.
    Di Marco V; Ferraro D; Almasio P; Vaccaro A; Parisi P; Cappello M; Cino N; Di Stefano R; Craxì A
    J Viral Hepat; 2002 Sep; 9(5):354-9. PubMed ID: 12225330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C.
    Falcão F; Lopes C; Viegas E; Perez R; Aldir I; Farinha H; Carvalho A; Mirco A; Marques S; Bana E Costa T; Miranda AC; Lebre L; Peixe P; Chagas C; Mansinho K; Correia JM
    Acta Med Port; 2019 Mar; 32(3):189-194. PubMed ID: 30946789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
    Tsubota A; Arase Y; Someya T; Suzuki Y; Suzuki F; Saitoh S; Ikeda K; Akuta N; Hosaka T; Kobayashi M; Kumada H
    J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.
    Ponziani FR; Viganò R; Iemmolo RM; Donato MF; Rendina M; Toniutto P; Pasulo L; Morelli MC; Burra P; Miglioresi L; Merli M; Di Paolo D; Fagiuoli S; Gasbarrini A; Pompili M; ; Belli L; Gerunda GE; Marino M; Montalti R; Di Benedetto F; De Ruvo N; Rigamonti C; Colombo M; Rossi G; Di Leo A; Lupo L; Memeo V; Bringiotti R; Zappimbulso M; Bitetto D; Vero V; Colpani M; Fornasiere E; Pinna AD; Morelli MC; Bertuzzo V; De Martin E; Senzolo M; Ettorre GM; Visco-Comandini U; Antonucci G; Angelico M; Tisone G; Giannelli V; Giusto M
    Dig Liver Dis; 2014 May; 46(5):440-5. PubMed ID: 24635906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
    Elmasry S; Wadhwa S; Bang BR; Cook L; Chopra S; Kanel G; Kim B; Harper T; Feng Z; Jerome KR; Kahn JA; Saito T
    Gastroenterology; 2017 Feb; 152(3):550-553.e8. PubMed ID: 27838287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up.
    Fabrizi F; Aghemo A; Lampertico P; Fraquelli M; Cresseri D; Moroni G; Passerini P; Donato FM; Messa P
    Int J Artif Organs; 2018 Jun; 41(6):306-318. PubMed ID: 29595085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study of two antiviral agents for hepatitis C genotype 1.
    Lok AS; Gardiner DF; Lawitz E; Martorell C; Everson GT; Ghalib R; Reindollar R; Rustgi V; McPhee F; Wind-Rotolo M; Persson A; Zhu K; Dimitrova DI; Eley T; Guo T; Grasela DM; Pasquinelli C
    N Engl J Med; 2012 Jan; 366(3):216-24. PubMed ID: 22256805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retreatment with peginterferon and ribavirin in chronic hepatitis C.
    Jo YM; Lee SW; Han SY; Baek YH; Kim SY; Kim WJ; Ahn JH; Lee JY
    World J Gastroenterol; 2015 Feb; 21(6):1994-9. PubMed ID: 25684969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?
    Brochot E; Bodeau S; Duverlie G
    Ther Drug Monit; 2015 Aug; 37(4):550-1. PubMed ID: 25525764
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
    Takayama K; Furusyo N; Ogawa E; Ikezaki H; Shimizu M; Murata M; Hayashi J
    World J Gastroenterol; 2015 Apr; 21(15):4696-706. PubMed ID: 25914481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.
    Gevers TJ; Burger D; Schipper-Reintjes E; Kooistra MP; Richter C
    Neth J Med; 2016 Jun; 74(5):225-7. PubMed ID: 27323683
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.
    Jun BG; Park EJ; Lee WC; Jang JY; Jeong SW; Kim YD; Cheon GJ; Cho YS; Lee SH; Kim HS; Lee YN; Kim SG; Kim YS; Kim BS
    Korean J Intern Med; 2019 Sep; 34(5):989-997. PubMed ID: 29529840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virological response in a treatment-experienced patient with hepatitis C virus genotype 6 infection: Follow-up on a reported case.
    Spooner LM; Abraham GM
    Am J Health Syst Pharm; 2017 Apr; 74(8):555. PubMed ID: 28389452
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.
    Taneja S; Duseja A; De A; Kumar V; Ramachandran R; Sharma A; Dhiman RK; Gupta KL; Chawla Y
    Nephrology (Carlton); 2018 Sep; 23(9):876-882. PubMed ID: 28703905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.